Inscitech Meet on
Genetics & Genome Research
IMGENETICS2026
Copenhagen, Denmark June 15-17, 2026
Early Bird Registration October 17, 2025
Dr. Michael Lim
Founder & CEO cell Genesis SingaporeWelcome Message
Dear Delegates,
It is with great pleasure that I welcome you all to the Inscitech Meet on Genetics & Genome Research (IMGENETICS2026), scheduled to take place from June 15–17, 2026, in the beautiful city of Copenhagen, Denmark.
As Chairperson of this esteemed gathering, I am honored to extend my warmest greetings to researchers, clinicians, industry experts, and students from around the world. This event aims to bring together brilliant minds to share the latest advancements, groundbreaking research, and transformative insights in the fields of genetics and genome science.
We look forward to an engaging and inspiring meeting that fosters collaboration, innovation, and lasting professional connections. I encourage each of you to actively participate and take full advantage of the opportunities this event presents.
Welcome to IMGENETICS2026 — let us make it a memorable and impactful experience together.
Warm regards,
Dr. Michael Lim
Chairperson
IMGENETICS2026
Dr. Gulsen Meral
Founder at Epigenetic CoachingUnited KingdomWelcome Message
Associate Professor Gülsen Meral graduated from Istanbul University Cerrahpa?a School of Medicine in 1994. She became a specialist in paediatrics in 2001 . She is Associate Professor in Pediatrics and worked as a specialist as well as deputy chief physician and chief physician at several hospitals. She was the Rector’s advisor between 2019-2021 at the Northern Cyprus ITU. She is also an Acupuncture instructor. She worked as a Nutrigenetics graduate course and lecturer and gave undergraduate and graduate courses on child development. She has many national and international publications, and worked on editorial boards and as reviewers. She has a Master's Degree in Hospital Management. She has a Turkish language literature undergraduate education. She completed PhD program in Medical Genetics. In addition to her scientific achievements, she is ambitious about poetry and has 5 poetry books. She is the Founder of the Nutrigenetics and Epigenetics Association, and has memberships in the Green Crescent and Rumelia Association, Istanbul Acupuncture Association, and International Society of Nutrigenetics & Nutrigenomics. She participated in the first and second International Epigenetic Congress as the president. She is still the organizer and educator of the Epigenetic Coaching Program. She is actively giving trainings on Nutrigenetic & Epigenetic Counselling to health professionals from all over the World as a certified CPD program. She continues research and training as the founder and manager of Epigenetic Coaching.
About Conference
Inscitech Meet on Genetics & Genome Research
Inscitech Meet on Genetics & Genome Research (IMGENETICS2026) is an international conference dedicated to showcasing the latest advancements, innovations, and research in the dynamic fields of Genetics and Genome Research. Scheduled to take place from June 15-17, 2026 in the vibrant city of Copenhagen, Denmark IMGENETICS2026 brings together leading academics, researchers, doctors, and industry professionals from around the globe.
Organized by InSciTech Summits, this three-day event provides a multidisciplinary platform for exchanging cutting-edge ideas, discussing real-world applications, and fostering collaborations across academia and industry. The program will feature plenary and keynote talks, technical sessions, interactive panels, and networking opportunities designed to inspire innovation and promote technological advancement.
Market Analysis- IMGENETICS2026
the genomics market is valued at approximately USD 59.28 billion and is projected to reach USD 118.67 billion by 2030, growing at a CAGR of 14.89%. Sub-segments such as genome sequencing and genomics services are also witnessing strong growth, with genome sequencing expected to rise from USD 26.31 billion in 2025 to USD 101.93 billion by 2034.
The personalized genomics segment is set to grow at an impressive CAGR of 17.73%, reaching over USD 52 billion by 2034. Key growth drivers include the adoption of next-generation and third-generation sequencing technologies, increased integration of artificial intelligence for data analysis, and a growing demand for personalized healthcare solutions. North America currently leads the market due to its robust healthcare infrastructure and investment in R&D, while the Asia-Pacific region is emerging rapidly, spurred by increasing healthcare expenditures and awareness. Notable trends include large-scale population genomics initiatives, ethical concerns surrounding consumer genomics data privacy (especially in light of events like the bankruptcy of 23andMe), and pioneering efforts in synthetic biology and de-extinction. Investment opportunities are abundant across diagnostics, therapeutics, agrigenomics, and bioinformatics platforms, although challenges such as regulatory complexities and data governance remain pivotal considerations for stakeholders
Best Regards,
Sara
Event Manager
Important Dates
- Conference Dates June 15-17, 2026
- Early Bird Registration October 17, 2025
- Abstract Submission Deadline May 01, 2026
- Conference Venue Copenhagen, Denmark
- First Round Abstract Submission September 30, 2025
- Second Round Abstract Submission
- Third Round Abstract Submission
Conference Updates and Collaborations
Plenary Speakers
Marco Vitali
Monza, Lombardy Italy
Marco Vitali
Monza, Lombardy ItalyBiography
Speech Title
FATEMEH AGHAJANI
Lombardy Italy
FATEMEH AGHAJANI
Lombardy ItalyBiography
Fatemeh Aghajani is a Master’s student in Molecular Biology and Genetics at the University of Pavia, with a strong academic and research focus on cancer biology. Her thesis work centers on understanding the biological effects of different radiotherapy modalities X-rays, protons, and carbon ions on head and neck cancer cell lines. By employing in vitro survival assays and radiobiological modeling, she investigates how particle therapies can overcome tumor radioresistance, one of the major obstacles in effective cancer treatment.
Her research is carried out at the National Center for Oncological Hadrontherapy (CNAO), where she explores how radiation quality influences DNA damage, clonogenic survival, and therapeutic potential. This work not only deepens understanding of the molecular and cellular responses of tumors to irradiation but also provides preclinical evidence for advancing personalized radiotherapy strategies.
Fatemeh’s academic foundation in Cell and Molecular Biology (BSc, Tehran) and her laboratory experience including PCR, Western blotting, immunohistochemistry, and cancer cell culture equip her with both the experimental and analytical skills necessary for cancer research. Her broader interests span tumor biology, mechanisms of radioresistance, and translational therapeutic strategies, reflecting her commitment to advancing oncology through integrative approaches that combine molecular biology with innovative cancer therapies.
Speech Title
Zeynep Esra Sahin
Istanbul Türkiye
Zeynep Esra Sahin
Istanbul TürkiyeBiography
Speech Title
Xiaobo Li
Qingdao, Shandong ChinaBiography
Xiaobo is leading the breeding design group in Crop Science of Kingagroot, an innovation-driven company in China. His focus area is spearheading the digital transformation of the breeding branch and delivering the top-notch elite inbred lines for commercial hybrid development. Xiaobo’s vision aligns well with Kingagroot’s commitment to global food security and quality. Under his leadership, Kingagroot breeding design group orchestrates key elements of modern breeding techniques, including state-of-the-art molecular and whole genome GWAS, assisted by advanced digital and AI algorithms. Fundamentally we balance the resources in the lab, in the field testing, as well as digital simulations. We are very committed to our customers. Our line development breeders design the high potential populations and balances eliteness and diversity. They spend heavy amount of time evaluating our germplasm at all key stages of the season. Their insights contribute heavily to our advancement decisions on top of the valuable data we collected.
Speech Title
Nosheen Khan
United Kingdom
Nosheen Khan
United KingdomBiography
Clinical Lead Dietitian and Educator: Educating students and healthcare professionals, nationally and internationally. UK - been involved in the assessment of post graduate and undergraduate dietetic students on the Communications Behaviour Change module collaborating with other Senior Leaders at Leeds Beckett University. Internationally - Visiting Professor in China, teaching students medical English and communication skills, health, healthcare, AI and healthcare. All underpinned by achieving a CELTA Level 5 teaching qualification at the highest level of a Grade A only achieved by 5% globally.
Speech Title
Dr. Joel I. Osorio
President of REGENERAGE MEXICO
Dr. Joel I. Osorio
President of REGENERAGE MEXICOBiography
Dr. Joel I. Osorio, MD, MSNM, MHSc, is a medical professional with extensive experience in biotechnology, mRNA, reprogramming, and regenerative medicine. He is known for his work in stem cell medicine and his contributions to the field of reprogramming medicine. Dr. Osorio is also involved in various medical organizations, including the World Academy of Medical Sciences (WAMS) and the American Academy of Anti-Aging Medicine (A4M).
Speech Title
A possible neuroregeneration on ASIA-A scale using a Medtronic Neurostimulator and combinatorial biologics: Bioquantine® and Wharton’s Jelly Mesenchymal Stem Cells as standardized therapy for No Option patients.
Dr. Jawad Alzeer
University of Zurich Switzerland
Dr. Jawad Alzeer
University of Zurich SwitzerlandBiography
I am Jawad Alzeer, a researcher at the University of Zurich with a deep interest in lifestyle medicine, holistic health, and integrative approaches to disease prevention and healing. My academic journey blends modern biomedical science with traditional knowledge systems to better understand how lifestyle choices shape our health at both the cellular and energetic levels.
My core focus lies in developing the Lifestylopathy framework, a concept I introduced to redefine chronic disease as a consequence of disrupted lifestyle patterns rather than isolated biological events. Lifestylopathy views the body as an interconnected system where energy, rhythm, and flow are essential for maintaining balance and vitality. Through this lens, I aim to highlight how conscious lifestyle changes—such as breathwork, nutrition, movement, and sleep—can restore physiological harmony and enhance the body’s natural healing capabilities.
Speech Title
Scott Themsen
Copenhagen Denmark
Scott Themsen
Copenhagen DenmarkBiography
Scott Themsen is a passionate molecular biologist and geneticist with expertise in medicine, cell function, and human physiology. I am particularly interested in how cellular mechanisms drive dynamic processes in health and disease, including conditions such as diabetes, genetic diseases, and muscle disorders. My scientific curiosity and dedication to problem solving drive me towards meaningful, translational research and laboratory work.
I am an outgoing person who quickly adapts to new environments and challenges. I have taught and supervised undergraduate, graduate, and PhD students with a focus on scientific methods and technical skills. I have gained over 600 hours of experience with microscopy, contributed to the development of a biosensor, and worked hands-on with both human and animal tissue materials. In addition, I have taken on research assistant assignments for 1.5 years, where I have helped implement sustainable work routines, handle chemical waste under GMP/GLP standards, and actively participate in symposia, conferences, and interdisciplinary research projects.
I am now seeking opportunities to apply my skills and experience in a professional context – whether in analytical laboratory work, research support or scientific development. I am particularly drawn to environments that value innovation, collaboration and scientific integrity. Let’s connect if you are passionate about advancing science or want to share experiences and insights!
Speech Title
Gulsen Meral
London United Kingdom
Gulsen Meral
London United KingdomBiography
Associate Professor Gülsen Meral graduated from Istanbul University Cerrahpaşa School of Medicine in 1994. She became a specialist in paediatrics in 2001 . She is Associate Professor in Pediatrics and worked as a specialist as well as deputy chief physician and chief physician at several hospitals. She was the Rector’s advisor between 2019-2021 at the Northern Cyprus ITU. She is also an Acupuncture instructor. She worked as a Nutrigenetics graduate course and lecturer and gave undergraduate and graduate courses on child development. She has many national and international publications, and worked on editorial boards and as reviewers. She has a Master's Degree in Hospital Management. She has a Turkish language literature undergraduate education. She completed PhD program in Medical Genetics. In addition to her scientific achievements, she is ambitious about poetry and has 5 poetry books. She is the Founder of the Nutrigenetics and Epigenetics Association, and has memberships in the Green Crescent and Rumelia Association, Istanbul Acupuncture Association, and International Society of Nutrigenetics & Nutrigenomics. She participated in the first and second International Epigenetic Congress as the president. She is still the organizer and educator of the Epigenetic Coaching Program. She is actively giving trainings on Nutrigenetic & Epigenetic Counselling to health professionals from all over the World as a certified CPD program. She continues research and training as the founder and manager of Epigenetic Coaching.
Speech Title
Dr. Michael Lim
Founder & CEO cell Genesis Singapore
Dr. Michael Lim
Founder & CEO cell Genesis SingaporeBiography
Dr. Michael Lim pioneered the 1st Allogeneic Stem Cell transplantation for the region of Asia Pacific in 2012 for Aesthetic medicine and using source from umbilical MSC and dental pulp MSC. because of the limitations on results, he further developed his Cell Enhancement X Cad Int (CEXCI) product line treatment, that made breakthroughs in the world of anti-ageing and diseases intervention. The 1st miraculous breakthrough, was CEXCI successfully slow down and reverse significantly the ageing process of a human. Following breakthroughs, CEXCI was able to help improve more than 40 incurable diseases inclusive of complicated disease and some selected terminal cases.
He has been training doctors ever since 2012 to present, in Malaysia, Singapore, Indonesia, Taiwan and China. He was also appointed as keynote speaker in 15 countries and 26 cities.
Speech Title
Malene Revsbech Christiansen
University of copenhagen Denmark
Malene Revsbech Christiansen
University of copenhagen DenmarkBiography
Speech Title
Mahbobe Jafariesfad
Copenhagen Denmark
Mahbobe Jafariesfad
Copenhagen DenmarkBiography
With a background in laboratory sciences and human genetics, I have developed a deep interest in the molecular mechanisms underlying disease—particularly in the context of cancer and immune-related disorders. My academic journey has led me to work across a range of research environments, from university labs to industry internships, where I’ve explored topics like cancer stem cell biology, circular RNAs, and antibody-based therapeutics.
During my master’s studies, I focused on gastric cancer and its association with cancer stem cell markers, which sparked a broader interest in the role of non-coding RNAs in disease progression. Later, as part of a research team at Bu Ali Research Institute, I became more involved in molecular techniques that allowed me to contribute to ongoing projects in cellular and genetic research.
Most recently, I joined Immunordic for an internship, where I worked on early-phase research into nanobody-based therapeutics, supporting efforts in oncology and neuroscience. This experience gave me valuable insight into translational research and the growing intersection between academic science and biotech innovation.
Being part of IMGENETICS2026 is an exciting opportunity for me to share ideas and learn from others working at the forefront of genetics and genome research.
Speech Title
Kareem Awad
University of Heidelberg Germany
Kareem Awad
University of Heidelberg GermanyBiography
Kareem Awad's research centers on human immune cell responses to various pathogenic and non-pathogenic stimuli, as well as their interactions with surrounding nerves and vascular cells. Throughout his experience in scientific institutions in Finland, Germany, and Egypt, his work has focused on how immune cells respond to pathogens, such as influenza strains, and abnormal environmental conditions, including hyperglycemia and tumor cells. His research primarily targets diseases like diabetes, influenza infections, and cancers, with a specific emphasis on glioblastoma, a type of brain tumor. Kareem holds a PhD in Pharmaceutical Sciences (Biochemistry) from Cairo University and is currently a researcher at the National Research Centre of Egypt.
Speech Title
Evangelos Gkogkas
Patras Greece
Evangelos Gkogkas
Patras GreeceBiography
Our philosofy is to respect your human integrity about the sceduled dental treatment we should provide to any problem you visit us for. With a continuing dental education to the fields of our interest under the best mendoring globaly. Based in Patra, West Greece, we make sure that everything will perform in the best way.
Speech Title
Sunrise in all ceramic cementation. A to z
Zhenglin Zhu
China Chongqing University
Zhenglin Zhu
China Chongqing UniversityBiography
Dr. Zhenglin Zhu, (Ph.D in Philosophy), now is a Professor of Biology in the School of Life Sciences, Chongqing University and the Standing Director of the Bioinformatics Society of Chongqing. Zhenglin Zhu received the Doctor’s Degree in Peking University and the researches currently focus on the population genomics and adaptive evolution. Until now, Zhenglin Zhu has published 37 articles in Cell Host & Microbe, Nature Communications, Plant Physiology and other SCI journals.
Speech Title
The nonstructural protein 4 mutation T492I may contribute to accelerated evolution of SARS-CoV-2 toward Omicron.
Invited Speakers
Mr. Benjamin Arthur
Partner & CISO in BiotechnologyUSA
Mr. Benjamin Arthur
Partner & CISO in BiotechnologyUSABiography
Experienced Executive with a demonstrated history of working in the Technology Management and Innovation and consulting industry. Strong professional skilled in Innovation in Healthcare solutions, Technology transfer, Entrepreneurship, and Strategic Partnerships.
Speech Title
Will be updated soon
Mr. Mohammed Al Kubati
MSAT Cell TherapyUSA
Mr. Mohammed Al Kubati
MSAT Cell TherapyUSABiography
will be updated soon
Speech Title
will be updated soon
Kusuma Nagammagari
University del piemonte Italy
Kusuma Nagammagari
University del piemonte ItalyBiography
Speech Title
Kaiser karim Labu
Guiyang, Guizhou China
Kaiser karim Labu
Guiyang, Guizhou ChinaBiography
Speech Title
Balbine Alindekon
Università degli Studi di Padova (UNIPD) Italy
Balbine Alindekon
Università degli Studi di Padova (UNIPD) ItalyBiography
Balbine ALINDEKON, a Beninese national and MSc holder, is a multidisciplinary professional trained at the intersection of biotechnology, agronomy, and environmental science. She has strengthened her expertise through master's programs in crop production: Biotechnology and plant breeding (University of Abomey-Calavi, Benin), Integrated crop management (University of Neuchâtel, Switzerland), and climate change and environmental management (a joint program between University of Padua, Italy and University of Johannesburg, South Africa). As a committed climate resilience activist involved in several organizations, she serves as a research assistant at the Genetics, Biotechnology and Seed Science Unit in Benin and at the African Centre for DNA Barcoding in South Africa. Her research and fields of interest focuse on sustainable agriculture, crop variety improvement, environment & human well being and the conservation of plant genetic resources.
She also has extensive skills in statistical data analysis, communication.
Speech Title
Scientific Sessions
- Human Genetics & Genomics
- Molecular Genetics
- Computational Genomics & Bioinformatics
- Genomic Technologies and Innovations
- Microbial and Metagenomics
- Reproductive Genetics
- Pharmacogenetics & Pharmacogenomics
- Structural Genomics
- Gene Therapy and Genomic Medicine
- Synthetic Genomics
- Forensic and Anthropological Genomics
- Medical and Clinical Genetics
- Cancer Genomics
- Functional Genomics
- Epigenetics and Chromatin Biology
- Agricultural and Plant Genomics
- Population and Evolutionary Genomics
- Neurogenetics
- Developmental Genetics
- Comparative Genomics
- Mitochondrial Genetics
- Systems Biology & Network Genomics
- Pediatric and Prenatal Genomics
Event Schedule
Welcome to the dedicated to building remarkable Schedule!
Participants From
Welcome to the dedicated participants !
